Clincosm LogoSign in Get a demo

multiple sclerosis, primary progressive

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • KYV-101 anti-CD19 CAR-T cell therapy
  • Standard lymphodepletion regimen
  • Palo Alto, California
    Stanford Multiple Sclerosis Center
Nov 13, 2023

Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

Not yet recruiting
  • Multiple Sclerosis (MS)
  • +6 more
  • Clemastine Fumarate
  • Placebo
  • San Francisco, California
    Sandler Neurosciences Building, Neurological Clinical Research U
Jan 23, 2023

Multiple Sclerosis, Primary Progressive Trial in Worldwide (fenebrutinib, ocrelizumab, )

Recruiting
  • Multiple Sclerosis, Primary Progressive
  • Homewood, Alabama
  • +211 more
Jan 5, 2023

Multiple Sclerosis, Primary Progressive Trial in Worldwide (Ocrelizumab, Placebo)

Recruiting
  • Multiple Sclerosis, Primary Progressive
  • Scottsdale, Arizona
  • +197 more
Jan 2, 2023

Multiple Sclerosis (MS) Patients

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • +2 more
    • (no location specified)
    Dec 15, 2022

    Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

    Completed
    • Multiple Sclerosis, Relapsing-Remitting
    • +2 more
    • 18F-DPA-714 and 18F-FDG
    • Paris, France
    • +1 more
    Sep 14, 2022

    Relapsing Multiple Sclerorsis, Multiple Sclerosis, Primary Progressive Trial in Worldwide (Ocrelizumab, Lumbar Puncture,

    Active, not recruiting
    • Relapsing Multiple Sclerorsis
    • Multiple Sclerosis, Primary Progressive
    • Palo Alto, California
    • +16 more
    Jul 26, 2022

    Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive Trial in Porto Alegre

    Not yet recruiting
    • Multiple Sclerosis, Chronic Progressive
    • +3 more
    • Nordic Walking (NWG)
    • +2 more
    • Porto Alegre, Rio Grande Do Sul, Brazil
      Universidade Federal do Rio Grande do Sul
    May 17, 2022

    Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Primary Progressive Trial in Kaposvár (Training groupe, PNF,

    Completed
    • Multiple Sclerosis, Chronic Progressive
    • Multiple Sclerosis, Primary Progressive
    • Training groupe
    • +3 more
    • Kaposvár, Somogy, Hungary
      Somogy Megyei Kaposi Mór Oktató Kórház
    Mar 24, 2022

    Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in San Francisco

    Recruiting
    • Multiple Sclerosis
    • +2 more
    • N-acetyl cysteine
    • Placebo
    • San Francisco, California
      University of California, San Francisco
    Mar 22, 2022

    Multiple Sclerosis, Primary Progressive Trial in Bordeaux, Limoges, Poitiers (Clinical assessment, Ecological evaluation,

    Recruiting
    • Multiple Sclerosis, Primary Progressive
    • Clinical assessment
    • +4 more
    • Bordeaux, France
    • +2 more
    Mar 31, 2022

    Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Marseille, Rennes (Magnetic

    Recruiting
    • Multiple Sclerosis, Primary Progressive
    • Multiple Sclerosis, Secondary Progressive
    • Magnetic Resonance Imaging
    • +3 more
    • Marseille, France
    • +1 more
    Jan 14, 2022

    MS-ResearchBiomarkerS

    Recruiting
    • Multiple Sclerosis
    • +10 more
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jan 26, 2022

      Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

      Completed
      • Multiple Sclerosis, Relapsing-Remitting
      • +2 more
      • Baltimore, Maryland
        Johns Hopkins University School of Medicine
      Dec 30, 2021

      Multiple Sclerosis, Primary Progressive Trial in Calgary (Hydroxychloroquine)

      Completed
      • Multiple Sclerosis, Primary Progressive
      • Calgary, Alberta, Canada
        MS Clinic Foothills Medical Centre
      Jul 28, 2021

      Multiple Sclerosis, Primary Progressive Trial in Qina, (aerobic exercise)

      Completed
      • Multiple Sclerosis, Primary Progressive
      • aerobic exercise
      • Qina,, Egypt
        South Valley University, Faculty of Physical Therapy
      Sep 3, 2020

      Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in United States (ibudilast, Placebo

      Completed
      Has Results
      • Multiple Sclerosis, Primary Progressive
      • Multiple Sclerosis, Secondary Progressive
      • Birmingham, Alabama
      • +27 more
      Jul 13, 2020

      Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Primary Progressive Trial in Kaposvár (Neurorehabilitation,

      Completed
      • Multiple Sclerosis, Chronic Progressive
      • Multiple Sclerosis, Primary Progressive
      • Neurorehabilitation
      • Physiotherapy
      • Kaposvár, Somogy, Hungary
        Somogy Megyei Kaposi Mór Teaching Hospital
      Apr 26, 2020

      Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Relapse Free Trial in

      Completed
      • Multiple Sclerosis, Secondary Progressive
      • +2 more
      • Sofia, Bulgaria
      • +7 more
      Apr 3, 2020

      Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

      Completed
      • Multiple Sclerosis, Relapsing-Remitting
      • +2 more
      • Baltimore, Maryland
        The Johns Hopkins Hospital
      Feb 8, 2018

      Multiple Sclerosis, Remittent Progressive, Multiple Sclerosis, Primary Progressive, Relapsing-Remitting Multiple Sclerosis Trial

      Completed
      • Multiple Sclerosis, Remittent Progressive
      • +4 more
      • Placebo
      • BIIB041 (fampridine)
      • Bunkyo-ku, Japan
      • +18 more
      Mar 17, 2017